DICLOFENAC SODIUM

DICLOFENAC SODIUM was reported 151588 times

DICLOFENAC SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LUPUS VULGARIS 1027 0.8151
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5712 0.7964
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 525 0.7859
3 SWOLLEN JOINT COUNT INCREASED 2469 0.7735
4 RHEUMATIC FEVER 3446 0.7723
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1494 0.7459
6 DUODENAL ULCER PERFORATION 5429 0.7293
7 HEPATIC ENZYME 106 0.7114
8 C-REACTIVE PROTEIN 615 0.6634
9 FACET JOINT SYNDROME 2151 0.6600
10 GRIP STRENGTH 150 0.6550
11 PEMPHIGUS 8157 0.6518
12 RHEUMATOID FACTOR POSITIVE 3573 0.6180
13 SWOLLEN JOINT COUNT 143 0.5720
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1178 0.5680
15 HAND DEFORMITY 7336 0.5588
16 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 100 0.5587
17 HYPOCHOLESTEROLAEMIA 190 0.5382
18 DISLOCATION OF VERTEBRA 1226 0.5370
19 HELICOBACTER INFECTION 5312 0.5163
20 RETINITIS 878 0.5078
21 X-RAY ABNORMAL 870 0.4860
22 MUSCLE INJURY 3992 0.4813
23 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 268 0.4777
24 EMBOLIA CUTIS MEDICAMENTOSA 351 0.4410
25 FOLLICULITIS 4546 0.4331
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2678 0.4119
27 PERIPHERAL VENOUS DISEASE 1681 0.4112
28 PERICARDITIS 6548 0.3893
29 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7114 0.3878
30 SERONEGATIVE ARTHRITIS 443 0.3866
31 SYNOVITIS 6825 0.3781
32 INSPIRATORY CAPACITY DECREASED 100 0.3610
33 GLOSSODYNIA 8004 0.3571
34 INTESTINAL DIAPHRAGM DISEASE 91 0.3262
35 C-REACTIVE PROTEIN ABNORMAL 1960 0.3052
36 DRUG EFFECT FASTER THAN EXPECTED 97 0.2913
37 DUCTUS ARTERIOSUS STENOSIS FOETAL 119 0.2793
38 BREAST CANCER STAGE III 1764 0.2721
39 PORPHYRIA ACUTE 377 0.2627
40 WOUND 7218 0.2580
41 BONE EROSION 865 0.2444
42 GRIP STRENGTH DECREASED 2136 0.2425
43 LIP DRY 2147 0.2361
44 SYSTEMIC LUPUS ERYTHEMATOSUS 8357 0.2352
45 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6855 0.2338
46 CONTRAINDICATED PRODUCT ADMINISTERED 6907 0.2279
47 BURSITIS 2689 0.2214
48 ONYCHOMADESIS 928 0.2209
49 JOINT RANGE OF MOTION DECREASED 2927 0.2180
50 IRRITABLE BOWEL SYNDROME 4461 0.2078
51 HYPERCHOLESTEROLAEMIA 1986 0.2055
52 WOUND INFECTION 2203 0.2010
53 DRUG TOLERANCE DECREASED 562 0.1999
54 LIVE BIRTH 1593 0.1902
55 DEAFNESS TRANSITORY 161 0.1885
56 OVERLAP SYNDROME 124 0.1771
57 BLEPHAROSPASM 1104 0.1752
58 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1841 0.1744
59 ONYCHOMYCOSIS 729 0.1660
60 FIBROMYALGIA 3973 0.1633
61 DRUG DISPENSED TO WRONG PATIENT 153 0.1604
62 AUTOIMMUNE DISORDER 1539 0.1577
63 FINGER DEFORMITY 715 0.1475
64 LIVER INJURY 3600 0.1465
65 IMPAIRED HEALING 4685 0.1426
66 ARTHROPATHY 7726 0.1389
67 NAIL DISORDER 1216 0.1388
68 TEMPERATURE REGULATION DISORDER 291 0.1305
69 DEATH NEONATAL 179 0.1286
70 JOINT DESTRUCTION 195 0.1253
71 PSORIATIC ARTHROPATHY 5043 0.1241
72 TYPE 2 DIABETES MELLITUS 4136 0.1227
73 MATERNAL EXPOSURE TIMING UNSPECIFIED 455 0.1210
74 EXOSTOSIS 1104 0.1208
75 RHEUMATOID LUNG 115 0.1204
76 OBESITY 1918 0.1203
77 SCIATICA 1829 0.1146
78 GASTRIC ULCER PERFORATION 145 0.1144
79 SACROILIITIS 212 0.1122
80 INFUSION RELATED REACTION 7298 0.1100
81 PRESCRIBED OVERDOSE 2104 0.1086
82 PRODUCT LABEL CONFUSION 630 0.1080
83 DISCOMFORT 6506 0.1065
84 INFUSION SITE REACTION 305 0.1020
85 HEPATIC ENZYME INCREASED 6932 0.1016
86 COELIAC DISEASE 992 0.1010
87 HIP ARTHROPLASTY 1539 0.1004
88 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1078 0.0973
89 THERAPEUTIC PRODUCT EFFECT DECREASED 4242 0.0946
90 BACK INJURY 1028 0.0944
91 BLISTER 5243 0.0933
92 LOWER RESPIRATORY TRACT INFECTION 4244 0.0932
93 OBSTRUCTIVE SLEEP APNOEA SYNDROME 135 0.0925
94 LUPUS-LIKE SYNDROME 831 0.0915
95 RHEUMATOID ARTHRITIS 10342 0.0910
96 PULMONARY FIBROSIS 1736 0.0904
97 LOWER LIMB FRACTURE 1721 0.0895
98 WALKING AID USER 582 0.0882
99 TENOSYNOVITIS 242 0.0876
100 OSTEOARTHRITIS 3714 0.0875
101 PUSTULAR PSORIASIS 298 0.0867
102 SWELLING 8091 0.0864
103 BLOOD CHOLESTEROL INCREASED 4026 0.0863
104 ANKYLOSING SPONDYLITIS 1129 0.0856
105 FOOT DEFORMITY 948 0.0854
106 GAIT INABILITY 2724 0.0814
107 MYOGLOBIN BLOOD INCREASED 123 0.0804
108 JOINT DISLOCATION 848 0.0801
109 SPONDYLITIS 285 0.0783
110 KOUNIS SYNDROME 177 0.0779
111 BREAST CANCER STAGE II 644 0.0773
112 ULCER HAEMORRHAGE 518 0.0765
113 DRUG INTOLERANCE 7375 0.0763
114 KNEE ARTHROPLASTY 1601 0.0760
115 C-REACTIVE PROTEIN INCREASED 2733 0.0750
116 ENTHESOPATHY 117 0.0748
117 JOINT SWELLING 8948 0.0741
118 PRODUCT USED FOR UNKNOWN INDICATION 93 0.0739
119 STOMATITIS 4390 0.0723
120 FOETAL DEATH 374 0.0720
121 ALLERGY TO CHEMICALS 88 0.0706
122 MATERNAL EXPOSURE DURING PREGNANCY 6284 0.0704
123 NIGHT SWEATS 2207 0.0684
124 EYE INJURY 207 0.0681
125 MUSCULOSKELETAL STIFFNESS 5866 0.0669
126 PRESCRIBED UNDERDOSE 1321 0.0662
127 SYNOVIAL CYST 303 0.0656
128 NEPHROGENIC ANAEMIA 300 0.0647
129 TREATMENT FAILURE 5324 0.0642
130 FOOD ALLERGY 480 0.0621
131 REBOUND ACID HYPERSECRETION 187 0.0618
132 HYPERPARATHYROIDISM SECONDARY 152 0.0606
133 MOBILITY DECREASED 4327 0.0602
134 RASH VESICULAR 288 0.0595
135 WHEEZING 3521 0.0593
136 LIVER FUNCTION TEST INCREASED 1262 0.0587
137 INFLAMMATION 3021 0.0585
138 CONGENITAL ANOMALY 449 0.0579
139 DUODENAL ULCER 409 0.0579
140 SHOULDER ARTHROPLASTY 156 0.0579
141 PERIORBITAL OEDEMA 299 0.0575
142 ABDOMINAL DISCOMFORT 9533 0.0568
143 ILL-DEFINED DISORDER 3445 0.0567
144 SPINAL STENOSIS 231 0.0559
145 MUSCULOSKELETAL PAIN 2893 0.0552
146 DUODENAL ULCER HAEMORRHAGE 157 0.0548
147 DRUG TOLERANCE 277 0.0547
148 BLOOD PRESSURE DIASTOLIC ABNORMAL 139 0.0546
149 INJURY 3833 0.0545
150 LARGE INTESTINAL ULCER 148 0.0545
151 GASTRITIS EROSIVE 254 0.0544
152 PRODUCT USE IN UNAPPROVED INDICATION 13433 0.0541
153 TASTE DISORDER 1097 0.0540
154 BLOOD PRESSURE SYSTOLIC ABNORMAL 133 0.0538
155 NORMAL NEWBORN 292 0.0537
156 DRUG EFFECT LESS THAN EXPECTED 771 0.0520
157 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 117 0.0507
158 SLEEP DISORDER 3552 0.0503
159 PRODUCT USE ISSUE 9403 0.0500
160 OLIGOHYDRAMNIOS 166 0.0497
161 SPINAL FUSION SURGERY 201 0.0495
162 GENERAL PHYSICAL HEALTH DETERIORATION 5727 0.0494
163 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 845 0.0492
164 GASTROINTESTINAL DISORDER 4401 0.0491
165 OEDEMA 2647 0.0488
166 EXPOSURE DURING PREGNANCY 3028 0.0487
167 LUNG DISORDER 2387 0.0487
168 ADVERSE REACTION 641 0.0483
169 HEPATIC CIRRHOSIS 898 0.0477
170 ROAD TRAFFIC ACCIDENT 1993 0.0476
171 GASTRIC ULCER 896 0.0471
172 PLANTAR FASCIITIS 158 0.0471
173 DRUG-INDUCED LIVER INJURY 1473 0.0469
174 POLYARTHRITIS 246 0.0466
175 JOINT STIFFNESS 1223 0.0466
176 RHEUMATOID NODULE 126 0.0457
177 CREPITATIONS 136 0.0456
178 INJECTION SITE NECROSIS 93 0.0456
179 LIVER DISORDER 2020 0.0455
180 IMMUNODEFICIENCY 672 0.0450
181 LARGE INTESTINAL STENOSIS 90 0.0450
182 ALOPECIA 8795 0.0447
183 THERAPEUTIC PRODUCT EFFECT VARIABLE 172 0.0443
184 DELIRIUM 1523 0.0438
185 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 271 0.0438
186 INTENTIONAL PRODUCT USE ISSUE 3807 0.0434
187 HYPERSENSITIVITY 8057 0.0434
188 EAR INFECTION 1136 0.0426
189 EPILEPSY 1290 0.0422
190 VITAMIN B12 DECREASED 121 0.0419
191 MELAENA 913 0.0414
192 CONTUSION 3961 0.0411
193 THERAPEUTIC RESPONSE UNEXPECTED 1842 0.0410
194 FUNCTIONAL GASTROINTESTINAL DISORDER 140 0.0405
195 SINUSITIS 4146 0.0404
196 PEPTIC ULCER 134 0.0403
197 NECK PAIN 2206 0.0394
198 PREGNANCY 775 0.0387
199 PERIPHERAL SWELLING 5957 0.0386
200 BRAIN NATRIURETIC PEPTIDE INCREASED 119 0.0386
201 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2075 0.0378
202 TENDERNESS 390 0.0374
203 PERSONALITY DISORDER 98 0.0374
204 DRY MOUTH 3004 0.0370
205 MYOSITIS 331 0.0369
206 GASTRIC ULCER HAEMORRHAGE 204 0.0368
207 INFECTION 5315 0.0367
208 FIBROSIS 109 0.0354
209 TYPE I HYPERSENSITIVITY 124 0.0352
210 THERAPY NON-RESPONDER 1578 0.0351
211 GASTRIC PERFORATION 93 0.0341
212 OSTEOPOROSIS 1383 0.0336
213 EAR PAIN 652 0.0335
214 INCORRECT DOSAGE ADMINISTERED 162 0.0331
215 DISABILITY 655 0.0331
216 PHARYNGITIS 410 0.0330
217 SPINAL PAIN 385 0.0328
218 FOOT OPERATION 162 0.0327
219 HYPOAESTHESIA 4883 0.0326
220 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2307 0.0324
221 CONFUSIONAL STATE 5226 0.0323
222 HEPATITIS 824 0.0322
223 NASOPHARYNGITIS 5841 0.0317
224 DUODENITIS 97 0.0316
225 DYSPEPSIA 3094 0.0314
226 ABDOMINAL TENDERNESS 156 0.0314
227 VIRAL UPPER RESPIRATORY TRACT INFECTION 149 0.0313
228 NECROTISING FASCIITIS 110 0.0312
229 GENERAL SYMPTOM 232 0.0309
230 JOINT EFFUSION 212 0.0307
231 IRON DEFICIENCY ANAEMIA 275 0.0298
232 GASTROOESOPHAGEAL REFLUX DISEASE 2397 0.0297
233 DIVERTICULUM INTESTINAL 130 0.0297
234 SPINAL OSTEOARTHRITIS 259 0.0295
235 TOXIC EPIDERMAL NECROLYSIS 445 0.0293
236 MIGRAINE 2784 0.0291
237 INTERVERTEBRAL DISC DISORDER 124 0.0290
238 UPPER RESPIRATORY TRACT INFECTION 1341 0.0290
239 SUSPECTED OFF LABEL USE 130 0.0287
240 INFLAMMATORY MARKER INCREASED 142 0.0286
241 INTERVERTEBRAL DISC DEGENERATION 264 0.0285
242 HYPERTENSION 6031 0.0284
243 ARTHRITIS 2238 0.0284
244 UPPER GASTROINTESTINAL HAEMORRHAGE 468 0.0278
245 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 243 0.0275
246 TUBULOINTERSTITIAL NEPHRITIS 515 0.0275
247 ARTHRITIS BACTERIAL 112 0.0273
248 CHRONIC KIDNEY DISEASE 2066 0.0272
249 URTICARIA 4498 0.0268
250 ANTINUCLEAR ANTIBODY POSITIVE 87 0.0268
251 OVERWEIGHT 143 0.0266
252 BACK DISORDER 427 0.0262
253 ARTHRALGIA 10914 0.0262
254 CONJUNCTIVAL HYPERAEMIA 92 0.0258
255 TRICUSPID VALVE INCOMPETENCE 204 0.0257
256 LARGE INTESTINE PERFORATION 178 0.0256
257 NEPHROTIC SYNDROME 174 0.0254
258 ONYCHOCLASIS 174 0.0253
259 BLOOD UREA INCREASED 420 0.0251
260 THERAPEUTIC PRODUCT EFFECT DELAYED 114 0.0250
261 RASH 10830 0.0248
262 GASTROINTESTINAL PAIN 272 0.0247
263 PAIN 15154 0.0246
264 WEIGHT INCREASED 5522 0.0246
265 PULMONARY TOXICITY 174 0.0246
266 RENAL TUBULAR NECROSIS 240 0.0244
267 END STAGE RENAL DISEASE 443 0.0243
268 ASTHMA 2735 0.0242
269 MUSCULAR WEAKNESS 2733 0.0240
270 CONDITION AGGRAVATED 7210 0.0237
271 BLOOD PRESSURE DIASTOLIC INCREASED 109 0.0236
272 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1130 0.0235
273 WEIGHT FLUCTUATION 246 0.0235
274 IRON DEFICIENCY 105 0.0233
275 APPLICATION SITE RASH 321 0.0233
276 AMNESIA 1512 0.0232
277 ABDOMINAL PAIN UPPER 4754 0.0231
278 BLOOD PRESSURE SYSTOLIC INCREASED 447 0.0229
279 HAEMATEMESIS 581 0.0229
280 SEDATION 600 0.0229
281 DRUG INEFFECTIVE 30191 0.0229
282 MENISCUS INJURY 140 0.0227
283 RENAL FAILURE ACUTE 953 0.0224
284 SPINAL COLUMN STENOSIS 106 0.0224
285 RENAL CYST 176 0.0221
286 ANAPHYLACTIC REACTION 1222 0.0221
287 ANURIA 190 0.0221
288 EXPIRED PRODUCT ADMINISTERED 726 0.0218
289 INCORRECT PRODUCT ADMINISTRATION DURATION 471 0.0217
290 SENSATION OF FOREIGN BODY 183 0.0217
291 ANAPHYLACTIC SHOCK 558 0.0216
292 HUMERUS FRACTURE 104 0.0215
293 CONCOMITANT DISEASE AGGRAVATED 133 0.0215
294 MEDICATION ERROR 1197 0.0215
295 MUSCLE SPASTICITY 263 0.0214
296 SECRETION DISCHARGE 268 0.0214
297 GASTRITIS 559 0.0212
298 MEMORY IMPAIRMENT 2912 0.0212
299 RESPIRATORY DISORDER 630 0.0210
300 LIGAMENT RUPTURE 93 0.0210
301 OEDEMA PERIPHERAL 2553 0.0209
302 PAIN IN EXTREMITY 6126 0.0208
303 ANGIOEDEMA 913 0.0206
304 PURPURA 182 0.0205
305 UVEITIS 278 0.0205
306 VITAMIN D DEFICIENCY 199 0.0204
307 VAGINAL INFECTION 96 0.0204
308 PRODUCT COMPLAINT 513 0.0202
309 SKIN NECROSIS 105 0.0202
310 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 341 0.0201
311 GASTRIC HAEMORRHAGE 231 0.0201
312 GROIN PAIN 176 0.0200
313 PARAESTHESIA 3144 0.0200
314 NIGHTMARE 690 0.0199
315 OLIGURIA 123 0.0198
316 MUSCULOSKELETAL DISCOMFORT 341 0.0198
317 BLOOD URIC ACID INCREASED 114 0.0197
318 ADRENAL INSUFFICIENCY 237 0.0195
319 PATHOLOGICAL FRACTURE 99 0.0195
320 FREQUENT BOWEL MOVEMENTS 524 0.0194
321 WHITE BLOOD CELL COUNT INCREASED 744 0.0194
322 DECREASED APPETITE 4460 0.0192
323 CHEST PAIN 3552 0.0192
324 TENDON DISORDER 125 0.0192
325 GENERALISED ERYTHEMA 109 0.0191
326 FACE OEDEMA 323 0.0191
327 DYSLIPIDAEMIA 97 0.0191
328 ABNORMAL LOSS OF WEIGHT 130 0.0191
329 RESPIRATORY RATE INCREASED 168 0.0189
330 PYREXIA 6506 0.0188
331 HIATUS HERNIA 243 0.0187
332 HEPATIC STEATOSIS 348 0.0187
333 APPLICATION SITE SWELLING 93 0.0186
334 MOVEMENT DISORDER 599 0.0186
335 RECTAL HAEMORRHAGE 800 0.0186
336 SPINAL DISORDER 176 0.0186
337 ROTATOR CUFF SYNDROME 238 0.0185
338 NEPHROLITHIASIS 850 0.0185
339 GAIT DISTURBANCE 3540 0.0185
340 RASH ERYTHEMATOUS 883 0.0185
341 INTERVERTEBRAL DISC PROTRUSION 403 0.0184
342 MUSCLE SPASMS 3364 0.0183
343 URINE OUTPUT DECREASED 160 0.0183
344 APPLICATION SITE PAIN 403 0.0183
345 PRE-EXISTING CONDITION IMPROVED 114 0.0182
346 SENSITIVITY TO WEATHER CHANGE 96 0.0182
347 PYELONEPHRITIS 158 0.0182
348 LYMPHOEDEMA 126 0.0182
349 FLUID RETENTION 924 0.0181
350 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1292 0.0181
351 MUSCULOSKELETAL CHEST PAIN 281 0.0181
352 SHOCK HAEMORRHAGIC 147 0.0180
353 ADVERSE DRUG REACTION 1615 0.0180
354 GAMMA-GLUTAMYLTRANSFERASE INCREASED 398 0.0179
355 INCREASED UPPER AIRWAY SECRETION 92 0.0179
356 ERYSIPELAS 90 0.0179
357 APPLICATION SITE VESICLES 116 0.0179
358 BLOOD PRESSURE DIASTOLIC DECREASED 132 0.0179
359 ADVERSE EVENT 1646 0.0178
360 BLOOD LACTATE DEHYDROGENASE INCREASED 283 0.0178
361 ACUTE KIDNEY INJURY 2705 0.0177
362 DIARRHOEA HAEMORRHAGIC 164 0.0175
363 FATIGUE 13618 0.0175
364 HYPERKALAEMIA 610 0.0174
365 NERVE COMPRESSION 160 0.0173
366 TOOTH ABSCESS 176 0.0173
367 BRONCHOSPASM 246 0.0172
368 PSORIASIS 2249 0.0172
369 DYSSTASIA 501 0.0171
370 THERMAL BURN 121 0.0170
371 SCOLIOSIS 104 0.0168
372 SHOCK 386 0.0168
373 BACK PAIN 3895 0.0167
374 IMPAIRED GASTRIC EMPTYING 225 0.0165
375 PRURITUS 6339 0.0165
376 DEFORMITY 154 0.0165
377 DISSEMINATED INTRAVASCULAR COAGULATION 231 0.0164
378 HYPERVENTILATION 95 0.0164
379 NODULE 213 0.0163
380 POSTOPERATIVE WOUND INFECTION 110 0.0163
381 INGUINAL HERNIA 99 0.0163
382 BODY TEMPERATURE INCREASED 332 0.0163
383 FAECES DISCOLOURED 352 0.0162
384 LOWER GASTROINTESTINAL HAEMORRHAGE 120 0.0162
385 SLEEP APNOEA SYNDROME 309 0.0162
386 DERMATITIS ALLERGIC 203 0.0161
387 OBSTRUCTIVE AIRWAYS DISORDER 179 0.0161
388 TENDONITIS 248 0.0160
389 ATRIAL SEPTAL DEFECT 134 0.0160
390 NEPHROPATHY 149 0.0159
391 RASH MACULO-PAPULAR 355 0.0159
392 HYPERAESTHESIA 131 0.0159
393 DEPRESSION 3620 0.0159
394 DECREASED IMMUNE RESPONSIVENESS 156 0.0159
395 LIGAMENT SPRAIN 157 0.0159
396 ERYTHEMA MULTIFORME 148 0.0159
397 ULCER 252 0.0158
398 FEELING HOT 969 0.0158
399 BLOOD ALKALINE PHOSPHATASE INCREASED 389 0.0156
400 PLATELET COUNT INCREASED 204 0.0156
401 URINE ODOUR ABNORMAL 92 0.0156
402 BODY TEMPERATURE DECREASED 154 0.0156
403 BLOOD ALBUMIN DECREASED 124 0.0156
404 BRONCHITIS 1157 0.0156
405 OFF LABEL USE 13654 0.0156
406 SKIN LESION 427 0.0156
407 MUSCULOSKELETAL DISORDER 296 0.0155
408 PHARYNGEAL SWELLING 152 0.0155
409 STEVENS-JOHNSON SYNDROME 344 0.0155
410 OESOPHAGITIS 169 0.0155
411 RENAL INJURY 457 0.0154
412 VOMITING 7220 0.0153
413 COLITIS ISCHAEMIC 103 0.0153
414 INSOMNIA 4062 0.0152
415 PRODUCT PRESCRIBING ERROR 363 0.0152
416 SEASONAL ALLERGY 215 0.0152
417 NEURALGIA 367 0.0151
418 RENAL FAILURE 2004 0.0151
419 FLANK PAIN 141 0.0150
420 HYPERHIDROSIS 1927 0.0149
421 BLOOD IRON DECREASED 177 0.0149
422 CYST 184 0.0148
423 LEUKOCYTOSIS 268 0.0148
424 LIMB INJURY 402 0.0148
425 PRODUCT ADMINISTRATION INTERRUPTED 116 0.0148
426 GOUT 265 0.0148
427 POST PROCEDURAL INFECTION 120 0.0147
428 ABDOMINAL DISTENSION 1538 0.0147
429 RIB FRACTURE 303 0.0147
430 HYPERLIPIDAEMIA 176 0.0147
431 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 114 0.0147
432 AUTOIMMUNE HEPATITIS 102 0.0147
433 CARPAL TUNNEL SYNDROME 205 0.0146
434 LYMPHOMA 226 0.0146
435 LARYNGEAL OEDEMA 90 0.0146
436 ESCHERICHIA INFECTION 120 0.0146
437 DRUG INTERACTION 2313 0.0146
438 MULTI-ORGAN FAILURE 251 0.0145
439 GASTROINTESTINAL HAEMORRHAGE 1213 0.0145
440 ABDOMINAL PAIN 3374 0.0145
441 JOINT INJURY 309 0.0145
442 ECCHYMOSIS 99 0.0144
443 OSTEOPENIA 219 0.0144
444 FOOT FRACTURE 273 0.0144
445 PNEUMONIA 4660 0.0144
446 ARTERIOSCLEROSIS CORONARY ARTERY 95 0.0143
447 UNDERDOSE 1046 0.0143
448 MUSCLE STRAIN 123 0.0142
449 JAUNDICE 381 0.0141
450 HYPOKINESIA 205 0.0141
451 HYPERTRANSAMINASAEMIA 98 0.0141
452 PULMONARY CONGESTION 185 0.0140
453 HAEMATOCHEZIA 773 0.0140
454 PERITONITIS 290 0.0140
455 MALAISE 6118 0.0139
456 CONCUSSION 108 0.0139
457 BLOOD CREATININE INCREASED 907 0.0139
458 DYSPNOEA 7862 0.0139
459 ASTHENIA 5222 0.0139
460 SKIN ULCER 359 0.0139
461 DECUBITUS ULCER 113 0.0139
462 EOSINOPHILIA 242 0.0138
463 MOUTH ULCERATION 290 0.0137
464 CIRCULATORY COLLAPSE 233 0.0137
465 DIZZINESS 6811 0.0136
466 TENDON RUPTURE 168 0.0136
467 HEADACHE 8530 0.0136
468 DYSPNOEA EXERTIONAL 512 0.0136
469 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2447 0.0136
470 HAEMODIALYSIS 114 0.0136
471 LIMB DISCOMFORT 419 0.0135
472 HYPOALBUMINAEMIA 105 0.0135
473 HYDRONEPHROSIS 101 0.0135
474 DRUG ERUPTION 239 0.0135
475 SPLENOMEGALY 157 0.0134
476 HAEMATOCRIT DECREASED 265 0.0134
477 TACHYCARDIA 1187 0.0133
478 ANKLE FRACTURE 206 0.0133
479 OROPHARYNGEAL DISCOMFORT 119 0.0132
480 RASH PRURITIC 711 0.0131
481 BLOOD MAGNESIUM DECREASED 113 0.0131
482 INTENTIONAL PRODUCT MISUSE 1144 0.0131
483 FEEDING DISORDER 265 0.0131
484 HYPOPHAGIA 334 0.0131
485 MATERNAL EXPOSURE BEFORE PREGNANCY 89 0.0130
486 GASTROENTERITIS 190 0.0130
487 PALLOR 354 0.0130
488 BLOOD PRESSURE FLUCTUATION 311 0.0129
489 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2622 0.0129
490 COLITIS ULCERATIVE 578 0.0129
491 ALANINE AMINOTRANSFERASE INCREASED 791 0.0129
492 SKIN LACERATION 140 0.0129
493 OSTEOMYELITIS 233 0.0129
494 RESPIRATORY TRACT INFECTION 334 0.0128
495 CORONARY ARTERY DISEASE 388 0.0128
496 WEIGHT DECREASED 3571 0.0128
497 INJECTION SITE REACTION 880 0.0128
498 RENAL PAIN 134 0.0126
499 EYELID OEDEMA 146 0.0125
500 CYSTITIS 396 0.0124
501 DERMATITIS BULLOUS 90 0.0124
502 BURNING SENSATION 869 0.0124
503 GLOMERULAR FILTRATION RATE DECREASED 152 0.0124
504 HAND FRACTURE 87 0.0123
505 SENSORY DISTURBANCE 197 0.0123
506 HEART RATE DECREASED 431 0.0123
507 METABOLIC ACIDOSIS 391 0.0122
508 ASPARTATE AMINOTRANSFERASE INCREASED 649 0.0122
509 SPINAL COMPRESSION FRACTURE 101 0.0122
510 RENAL IMPAIRMENT 1026 0.0122
511 SCAR 209 0.0122
512 NEPHROPATHY TOXIC 137 0.0122
513 THERAPEUTIC RESPONSE DECREASED 740 0.0122
514 PRODUCT ADMINISTRATION ERROR 245 0.0121
515 MITRAL VALVE INCOMPETENCE 137 0.0121
516 BONE DENSITY DECREASED 379 0.0121
517 HEAD DISCOMFORT 214 0.0121
518 VISUAL IMPAIRMENT 1493 0.0120
519 DEAFNESS 315 0.0120
520 SCRATCH 127 0.0120
521 EATING DISORDER 256 0.0120
522 ARTHROPOD BITE 89 0.0120
523 ELECTROCARDIOGRAM ABNORMAL 94 0.0120
524 ANOREXIA 154 0.0119
525 HAEMOGLOBIN DECREASED 1227 0.0119
526 PERIPHERAL COLDNESS 164 0.0119
527 ARTERIOSCLEROSIS 112 0.0119
528 ACUTE MYOCARDIAL INFARCTION 349 0.0118
529 FALL 3914 0.0117
530 SCAB 134 0.0117
531 PNEUMOTHORAX 186 0.0117
532 HYPOKALAEMIA 540 0.0117
533 DIARRHOEA 7537 0.0117
534 DERMATITIS CONTACT 133 0.0117
535 PRODUCT ODOUR ABNORMAL 122 0.0116
536 NAUSEA 9177 0.0116
537 BLOOD POTASSIUM INCREASED 188 0.0116
538 GENERALISED OEDEMA 143 0.0115
539 POLYNEUROPATHY 138 0.0115
540 KIDNEY INFECTION 226 0.0115
541 ILEUS 143 0.0115
542 SUICIDE ATTEMPT 697 0.0115
543 GASTROINTESTINAL INFECTION 103 0.0115
544 STAPHYLOCOCCAL INFECTION 379 0.0115
545 POOR QUALITY SLEEP 247 0.0115
546 HAEMATOMA 297 0.0115
547 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 293 0.0114
548 GASTROENTERITIS VIRAL 205 0.0113
549 LABORATORY TEST ABNORMAL 335 0.0113
550 OROPHARYNGEAL PAIN 1047 0.0113
551 COLD SWEAT 198 0.0112
552 BODY HEIGHT DECREASED 120 0.0112
553 FOETAL EXPOSURE DURING PREGNANCY 911 0.0112
554 BLOOD PRESSURE DECREASED 744 0.0112
555 RHINITIS 90 0.0112
556 PARAESTHESIA ORAL 161 0.0111
557 HYPOCALCAEMIA 211 0.0111
558 DIVERTICULITIS 308 0.0111
559 CONJUNCTIVITIS 206 0.0111
560 PANCREATITIS 584 0.0110
561 CHOLECYSTITIS 131 0.0110
562 POLYURIA 90 0.0110
563 HEPATIC FUNCTION ABNORMAL 410 0.0110
564 KNEE OPERATION 108 0.0110
565 FACIAL PAIN 98 0.0110
566 ATELECTASIS 106 0.0110
567 VASCULITIS 127 0.0109
568 RED BLOOD CELL COUNT DECREASED 311 0.0109
569 ANXIETY 3081 0.0108
570 CHOLELITHIASIS 355 0.0108
571 PRODUCTIVE COUGH 516 0.0108
572 PAIN IN JAW 306 0.0108
573 ANAEMIA 2060 0.0108
574 NERVE INJURY 120 0.0108
575 DEPRESSED LEVEL OF CONSCIOUSNESS 426 0.0108
576 RHABDOMYOLYSIS 449 0.0108
577 SKIN DISORDER 359 0.0108
578 ACUTE HEPATIC FAILURE 147 0.0107
579 LACTIC ACIDOSIS 348 0.0107
580 NEUTROPHIL COUNT INCREASED 110 0.0107
581 POOR VENOUS ACCESS 111 0.0107
582 SKIN REACTION 151 0.0107
583 ACUTE RESPIRATORY FAILURE 206 0.0107
584 CELLULITIS 538 0.0107
585 BLOOD SODIUM DECREASED 201 0.0107
586 QUALITY OF LIFE DECREASED 143 0.0106
587 INTENTIONAL OVERDOSE 682 0.0106
588 BLOOD CREATINE PHOSPHOKINASE INCREASED 306 0.0106
589 URINARY RETENTION 354 0.0106
590 BLOOD PRESSURE INCREASED 1620 0.0106
591 DENTAL CARIES 117 0.0106
592 COAGULOPATHY 176 0.0106
593 HAEMORRHOIDS 206 0.0106
594 ORAL CANDIDIASIS 139 0.0105
595 POISONING DELIBERATE 100 0.0105
596 BLOOD URINE PRESENT 200 0.0105
597 SEROTONIN SYNDROME 202 0.0105
598 SWOLLEN TONGUE 328 0.0105
599 CHROMATURIA 237 0.0105
600 CARDIOMEGALY 129 0.0105
601 ORAL HERPES 204 0.0104
602 PETECHIAE 109 0.0104
603 PRODUCT QUALITY ISSUE 1416 0.0104
604 HYPONATRAEMIA 587 0.0104
605 LYMPHADENOPATHY 368 0.0104
606 HYPOTHYROIDISM 330 0.0103
607 PRURITUS GENERALISED 223 0.0103
608 APPLICATION SITE ERYTHEMA 270 0.0103
609 MYOCARDIAL ISCHAEMIA 117 0.0103
610 DRY EYE 513 0.0103
611 MICTURITION URGENCY 117 0.0102
612 ABDOMINAL PAIN LOWER 259 0.0102
613 LIP SWELLING 341 0.0102
614 GASTRIC DISORDER 350 0.0102
615 LUNG INFILTRATION 90 0.0102
616 CATARACT 606 0.0102
617 HEPATOMEGALY 100 0.0102
618 URINARY INCONTINENCE 301 0.0101
619 SEPTIC SHOCK 442 0.0101
620 INTESTINAL PERFORATION 114 0.0101
621 INTERNATIONAL NORMALISED RATIO INCREASED 289 0.0101
622 CEREBRAL INFARCTION 247 0.0101
623 ERYTHEMA 2074 0.0101
624 TOOTH FRACTURE 111 0.0101
625 HERPES ZOSTER 578 0.0100
626 ANGINA PECTORIS 288 0.0100
627 BLOOD CALCIUM DECREASED 113 0.0100
628 LOCALISED INFECTION 243 0.0100
629 CYANOSIS 158 0.0100
630 INTERSTITIAL LUNG DISEASE 486 0.0100
631 ECONOMIC PROBLEM 152 0.0100
632 PHOTOPHOBIA 188 0.0100
633 SINUS CONGESTION 135 0.0100
634 LOSS OF CONSCIOUSNESS 1280 0.0100
635 ASPIRATION 109 0.0099
636 INCONTINENCE 105 0.0099
637 PHOTOSENSITIVITY REACTION 164 0.0099
638 INFLAMMATORY BOWEL DISEASE 97 0.0099
639 ABSCESS 158 0.0099
640 PLEURAL EFFUSION 601 0.0099
641 HEPATOCELLULAR INJURY 140 0.0099
642 DECREASED ACTIVITY 106 0.0098
643 EYE SWELLING 365 0.0098
644 SKIN INFECTION 110 0.0098
645 OXYGEN SATURATION DECREASED 549 0.0098
646 CHEST DISCOMFORT 996 0.0097
647 THROMBOCYTOPENIA 1086 0.0097
648 URINARY TRACT INFECTION 1655 0.0097
649 BLOOD BILIRUBIN INCREASED 262 0.0097
650 HAEMATURIA 332 0.0097
651 DIZZINESS POSTURAL 94 0.0097
652 METASTASES TO BONE 159 0.0097
653 TINNITUS 445 0.0097
654 COLITIS 366 0.0096
655 CANDIDA INFECTION 163 0.0096
656 SKIN HAEMORRHAGE 143 0.0096
657 POST PROCEDURAL COMPLICATION 185 0.0096
658 METASTASES TO LUNG 111 0.0096
659 BONE DISORDER 175 0.0096
660 WRIST FRACTURE 115 0.0096
661 SPINAL OPERATION 118 0.0096
662 BIPOLAR DISORDER 104 0.0096
663 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 323 0.0096
664 NOCTURIA 116 0.0095
665 PULMONARY HYPERTENSION 199 0.0095
666 SNEEZING 214 0.0095
667 SPUTUM DISCOLOURED 90 0.0095
668 RESTLESS LEGS SYNDROME 172 0.0094
669 DISORIENTATION 374 0.0094
670 SPINAL FRACTURE 186 0.0093
671 FEMUR FRACTURE 287 0.0093
672 MIDDLE INSOMNIA 173 0.0093
673 BONE PAIN 542 0.0092
674 EYE PAIN 521 0.0092
675 SINUS TACHYCARDIA 131 0.0092
676 ILLNESS 948 0.0092
677 TACHYPNOEA 125 0.0092
678 PARALYSIS 131 0.0091
679 MUSCLE TWITCHING 210 0.0091
680 TOOTH INFECTION 120 0.0091
681 EYE HAEMORRHAGE 121 0.0091
682 BLADDER DISORDER 90 0.0091
683 EAR DISCOMFORT 93 0.0091
684 DRUG PRESCRIBING ERROR 174 0.0090
685 PROTEINURIA 172 0.0090
686 HALLUCINATION, VISUAL 191 0.0090
687 RASH PAPULAR 202 0.0090
688 MYALGIA 1532 0.0090
689 HEAD INJURY 285 0.0090
690 LIVER FUNCTION TEST ABNORMAL 261 0.0090
691 INITIAL INSOMNIA 92 0.0090
692 MASS 125 0.0089
693 SKIN DISCOLOURATION 411 0.0089
694 DYSURIA 329 0.0089
695 PULMONARY MASS 133 0.0089
696 THROAT TIGHTNESS 241 0.0089
697 APPLICATION SITE PRURITUS 201 0.0089
698 DYSPHONIA 518 0.0088
699 PRESYNCOPE 215 0.0088
700 RENAL DISORDER 412 0.0088
701 NASAL CONGESTION 519 0.0088
702 HYPERCALCAEMIA 109 0.0088
703 SOMNOLENCE 1773 0.0088
704 HEMIPARESIS 149 0.0088
705 PANCREATITIS ACUTE 197 0.0088
706 MALNUTRITION 98 0.0088
707 LEUKOPENIA 438 0.0087
708 CONSTIPATION 1895 0.0087
709 TOOTH LOSS 180 0.0087
710 ANHEDONIA 228 0.0087
711 TOOTHACHE 157 0.0087
712 AGRANULOCYTOSIS 161 0.0087
713 RESPIRATORY DEPRESSION 106 0.0086
714 DIPLOPIA 224 0.0086
715 MUSCLE RIGIDITY 103 0.0086
716 RASH MACULAR 301 0.0086
717 CLOSTRIDIUM DIFFICILE COLITIS 91 0.0086
718 BLOOD POTASSIUM DECREASED 258 0.0086
719 MUSCLE ATROPHY 108 0.0085
720 RHINORRHOEA 549 0.0085
721 LYMPHOCYTE COUNT DECREASED 150 0.0085
722 TRANSIENT ISCHAEMIC ATTACK 286 0.0085
723 BASAL CELL CARCINOMA 132 0.0085
724 HYPERTENSIVE CRISIS 94 0.0084
725 SWELLING FACE 548 0.0084
726 RESTLESSNESS 307 0.0084
727 MYOCLONUS 100 0.0084
728 COVID-19 PNEUMONIA 99 0.0084
729 VERTIGO 511 0.0084
730 PULMONARY OEDEMA 375 0.0084
731 INTENTIONAL SELF-INJURY 169 0.0084
732 INFLUENZA 929 0.0083
733 TRANSAMINASES INCREASED 185 0.0083
734 SEPSIS 926 0.0083
735 SMALL INTESTINAL OBSTRUCTION 102 0.0083
736 HYPOTENSION 1662 0.0083
737 ORAL DISCOMFORT 115 0.0083
738 ALTERED STATE OF CONSCIOUSNESS 179 0.0083
739 BRAIN OEDEMA 104 0.0082
740 WRONG TECHNIQUE IN DRUG USAGE PROCESS 299 0.0082
741 CHOLESTASIS 158 0.0082
742 ORTHOSTATIC HYPOTENSION 143 0.0082
743 PNEUMONIA ASPIRATION 205 0.0082
744 PHARYNGEAL OEDEMA 126 0.0082
745 PERICARDIAL EFFUSION 189 0.0082
746 COORDINATION ABNORMAL 114 0.0082
747 RESPIRATORY FAILURE 594 0.0081
748 COUGH 2260 0.0081
749 POISONING 101 0.0080
750 SYNCOPE 804 0.0080
751 TOOTH DISORDER 178 0.0080
752 GLAUCOMA 154 0.0080
753 VIRAL INFECTION 266 0.0080
754 INFUSION SITE PAIN 103 0.0080
755 PALPITATIONS 936 0.0080
756 DYSPHAGIA 756 0.0080
757 DEHYDRATION 1062 0.0080
758 HYPOAESTHESIA ORAL 120 0.0080
759 APHONIA 111 0.0079
760 OCULAR HYPERAEMIA 377 0.0079
761 SPEECH DISORDER 416 0.0079
762 ELECTROLYTE IMBALANCE 92 0.0079
763 LUNG INFECTION 123 0.0079
764 ERUCTATION 153 0.0079
765 PNEUMONITIS 213 0.0078
766 HAEMOPTYSIS 218 0.0078
767 ACUTE RESPIRATORY DISTRESS SYNDROME 138 0.0078
768 HEART RATE IRREGULAR 176 0.0078
769 HYPOXIA 274 0.0078
770 THERAPEUTIC RESPONSE SHORTENED 258 0.0078
771 HYPOMAGNESAEMIA 108 0.0077
772 IMMUNE SYSTEM DISORDER 102 0.0077
773 UPPER LIMB FRACTURE 154 0.0077
774 CHILLS 904 0.0077
775 SURGERY 452 0.0077
776 APATHY 112 0.0077
777 TREMOR 1273 0.0077
778 DIABETES MELLITUS 584 0.0077
779 DYSARTHRIA 288 0.0076
780 CARDIOVASCULAR DISORDER 193 0.0076
781 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 396 0.0076
782 BALANCE DISORDER 655 0.0076
783 HEART RATE INCREASED 749 0.0076
784 IMPAIRED WORK ABILITY 161 0.0075
785 ABASIA 186 0.0075
786 SINUS DISORDER 149 0.0075
787 BACTERIAL INFECTION 140 0.0075
788 THERAPY PARTIAL RESPONDER 117 0.0075
789 EYE DISORDER 246 0.0075
790 MUSCLE TIGHTNESS 121 0.0075
791 HOT FLUSH 560 0.0074
792 ENCEPHALOPATHY 182 0.0074
793 RETCHING 158 0.0074
794 ATRIAL FIBRILLATION 714 0.0073
795 CARDIOMYOPATHY 108 0.0073
796 OVERDOSE 1572 0.0073
797 ACCIDENT 87 0.0073
798 PELVIC PAIN 132 0.0073
799 BRADYCARDIA 383 0.0072
800 RASH GENERALISED 187 0.0072
801 THYROID DISORDER 111 0.0072
802 SOPOR 95 0.0072
803 MALIGNANT MELANOMA 96 0.0072
804 HEPATIC FAILURE 214 0.0071
805 IMPAIRED QUALITY OF LIFE 102 0.0071
806 ORAL PAIN 158 0.0070
807 LOCAL SWELLING 123 0.0070
808 DRUG TOXICITY 96 0.0070
809 RESPIRATORY DISTRESS 194 0.0070
810 FEELING ABNORMAL 1683 0.0070
811 THROAT IRRITATION 315 0.0070
812 MENTAL DISORDER 305 0.0070
813 HEPATOTOXICITY 156 0.0070
814 INCORRECT DOSE ADMINISTERED 1597 0.0070
815 COMA 333 0.0070
816 POLLAKIURIA 291 0.0070
817 DERMATITIS 146 0.0070
818 APHASIA 210 0.0069
819 LACRIMATION INCREASED 210 0.0069
820 DRUG LEVEL INCREASED 115 0.0069
821 ECZEMA 363 0.0069
822 DYSKINESIA 281 0.0069
823 MUCOSAL INFLAMMATION 181 0.0069
824 INTENTIONAL DOSE OMISSION 197 0.0069
825 BLOOD TRIGLYCERIDES INCREASED 122 0.0069
826 CARDIAC FAILURE 554 0.0069
827 NEUROPATHY PERIPHERAL 656 0.0069
828 INTESTINAL OBSTRUCTION 259 0.0069
829 BLOOD PRESSURE ABNORMAL 136 0.0068
830 LETHARGY 393 0.0068
831 DEVICE RELATED INFECTION 105 0.0068
832 HALLUCINATION 508 0.0067
833 FLATULENCE 382 0.0067
834 HYPERSOMNIA 193 0.0067
835 EPISTAXIS 503 0.0067
836 PULMONARY EMBOLISM 639 0.0067
837 FUNGAL INFECTION 224 0.0067
838 PROSTATIC SPECIFIC ANTIGEN INCREASED 92 0.0067
839 PANCYTOPENIA 373 0.0067
840 HERNIA 129 0.0067
841 ASCITES 196 0.0067
842 FEELING COLD 185 0.0066
843 DISTURBANCE IN ATTENTION 358 0.0066
844 INJECTION SITE WARMTH 136 0.0066
845 MULTIPLE ORGAN DYSFUNCTION SYNDROME 187 0.0066
846 DEEP VEIN THROMBOSIS 428 0.0066
847 WHITE BLOOD CELL COUNT DECREASED 709 0.0065
848 RESPIRATORY TRACT CONGESTION 103 0.0065
849 OSTEONECROSIS 212 0.0064
850 PREMATURE BABY 194 0.0064
851 ARRHYTHMIA 305 0.0064
852 VISION BLURRED 883 0.0064
853 PRODUCT PRESCRIBING ISSUE 140 0.0064
854 CARDIAC ARREST 530 0.0064
855 DRUG ABUSE 534 0.0064
856 DEPRESSED MOOD 339 0.0064
857 PRODUCT USE COMPLAINT 101 0.0064
858 UNRESPONSIVE TO STIMULI 165 0.0064
859 HIP FRACTURE 203 0.0063
860 DELUSION 98 0.0063
861 LYMPHOPENIA 89 0.0063
862 BLINDNESS UNILATERAL 88 0.0062
863 RESPIRATORY ARREST 171 0.0062
864 DRUG EXPOSURE DURING PREGNANCY 211 0.0062
865 HAEMORRHAGE 648 0.0062
866 CEREBRAL HAEMORRHAGE 221 0.0062
867 PLATELET COUNT DECREASED 655 0.0061
868 FRACTURE 116 0.0061
869 THROMBOSIS 489 0.0061
870 MENTAL IMPAIRMENT 145 0.0060
871 TREATMENT NONCOMPLIANCE 327 0.0060
872 ACCIDENTAL EXPOSURE TO PRODUCT 613 0.0059
873 THIRST 106 0.0059
874 HYPERGLYCAEMIA 216 0.0059
875 TOXICITY TO VARIOUS AGENTS 997 0.0059
876 MULTIPLE FRACTURES 97 0.0059
877 SUICIDAL IDEATION 540 0.0059
878 NERVOUSNESS 308 0.0059
879 ISCHAEMIC STROKE 105 0.0059
880 SKIN EXFOLIATION 491 0.0058
881 ACTIVITIES OF DAILY LIVING IMPAIRED 115 0.0058
882 INFLUENZA LIKE ILLNESS 478 0.0058
883 FEAR 156 0.0058
884 VISUAL ACUITY REDUCED 191 0.0057
885 COVID-19 1003 0.0057
886 HYPOGLYCAEMIA 274 0.0056
887 HALLUCINATION, AUDITORY 89 0.0056
888 CARDIAC DISORDER 521 0.0056
889 EYE IRRITATION 320 0.0056
890 PROCEDURAL PAIN 154 0.0055
891 PANIC ATTACK 202 0.0055
892 DRUG EFFECT INCOMPLETE 200 0.0055
893 GALLBLADDER DISORDER 98 0.0055
894 DIABETES MELLITUS INADEQUATE CONTROL 97 0.0055
895 METASTASES TO LIVER 96 0.0055
896 FEELING JITTERY 104 0.0055
897 AGITATION 400 0.0054
898 DRUG ADMINISTRATION ERROR 167 0.0054
899 AGEUSIA 135 0.0054
900 DYSGEUSIA 400 0.0054
901 CHOKING 105 0.0054
902 ERECTILE DYSFUNCTION 138 0.0054
903 BLINDNESS 218 0.0053
904 NEUTROPHIL COUNT DECREASED 216 0.0053
905 FLUSHING 538 0.0053
906 CARDIO-RESPIRATORY ARREST 221 0.0053
907 CRYING 192 0.0053
908 SKIN FISSURES 103 0.0053
909 CLOSTRIDIUM DIFFICILE INFECTION 112 0.0051
910 INCREASED APPETITE 98 0.0051
911 PRODUCT DOSE OMISSION IN ERROR 145 0.0051
912 IRRITABILITY 304 0.0051
913 COGNITIVE DISORDER 233 0.0050
914 OSTEONECROSIS OF JAW 123 0.0050
915 PAIN OF SKIN 132 0.0049
916 MYOCARDIAL INFARCTION 855 0.0049
917 EYE PRURITUS 164 0.0049
918 ACCIDENTAL OVERDOSE 178 0.0049
919 NEOPLASM MALIGNANT 324 0.0048
920 SKIN CANCER 104 0.0048
921 MALIGNANT NEOPLASM PROGRESSION 493 0.0048
922 MENTAL STATUS CHANGES 133 0.0048
923 NERVOUS SYSTEM DISORDER 149 0.0048
924 HOSPITALISATION 733 0.0048
925 FULL BLOOD COUNT DECREASED 96 0.0048
926 SKIN IRRITATION 217 0.0047
927 MULTIPLE SCLEROSIS 226 0.0047
928 EMOTIONAL DISTRESS 564 0.0047
929 DISEASE RECURRENCE 220 0.0046
930 MOOD SWINGS 146 0.0046
931 HYPOACUSIS 197 0.0046
932 WITHDRAWAL SYNDROME 190 0.0045
933 ANGER 151 0.0045
934 PRODUCT DOSE OMISSION ISSUE 1308 0.0044
935 SEIZURE 513 0.0044
936 PSYCHOTIC DISORDER 131 0.0044
937 DEMENTIA 123 0.0044
938 EMOTIONAL DISORDER 134 0.0043
939 DISEASE PROGRESSION 514 0.0043
940 UNEVALUABLE EVENT 325 0.0043
941 INJECTION SITE PRURITUS 284 0.0042
942 INJECTION SITE SWELLING 324 0.0042
943 COMPLETED SUICIDE 351 0.0042
944 CEREBROVASCULAR ACCIDENT 711 0.0042
945 CONVULSION 238 0.0042
946 INJECTION SITE BRUISING 331 0.0041
947 VAGINAL HAEMORRHAGE 178 0.0041
948 INJECTION SITE ERYTHEMA 508 0.0041
949 MOOD ALTERED 111 0.0041
950 DRUG EFFECT DECREASED 218 0.0040
951 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 94 0.0040
952 INJECTION SITE MASS 149 0.0040
953 GLYCOSYLATED HAEMOGLOBIN INCREASED 98 0.0039
954 ABNORMAL DREAMS 107 0.0039
955 THERAPY INTERRUPTED 272 0.0038
956 INCORRECT DRUG ADMINISTRATION DURATION 107 0.0038
957 INJECTION SITE PAIN 1167 0.0038
958 SKIN BURNING SENSATION 270 0.0038
959 GASTRIC CANCER 94 0.0037
960 DRY SKIN 495 0.0037
961 LUNG NEOPLASM MALIGNANT 152 0.0037
962 ELECTROCARDIOGRAM QT PROLONGED 133 0.0037
963 CARDIAC FAILURE CONGESTIVE 296 0.0037
964 PRODUCT DOSE OMISSION 239 0.0037
965 DEVICE MALFUNCTION 254 0.0036
966 DRUG RESISTANCE 92 0.0036
967 PRODUCT SUBSTITUTION ISSUE 206 0.0036
968 ABORTION SPONTANEOUS 143 0.0036
969 BLOOD GLUCOSE INCREASED 671 0.0036
970 NEUTROPENIA 479 0.0035
971 INJECTION SITE RASH 108 0.0035
972 FEBRILE NEUTROPENIA 233 0.0035
973 MULTIPLE SCLEROSIS RELAPSE 238 0.0035
974 ABNORMAL BEHAVIOUR 137 0.0035
975 THERAPY CESSATION 175 0.0034
976 NEEDLE ISSUE 99 0.0034
977 AGGRESSION 166 0.0033
978 NEOPLASM PROGRESSION 108 0.0031
979 INJECTION SITE HAEMORRHAGE 233 0.0029
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 122 0.0026
981 BLOOD GLUCOSE DECREASED 125 0.0026
982 DERMATITIS ATOPIC 135 0.0026
983 DRUG WITHDRAWAL SYNDROME 222 0.0025
984 DEVICE ISSUE 221 0.0025
985 NO ADVERSE EVENT 432 0.0024
986 BREAST CANCER 222 0.0024
987 DRUG DOSE OMISSION 389 0.0024
988 DEATH 2022 0.0023
989 ACNE 172 0.0023
990 PROSTATE CANCER 171 0.0021
991 DRUG DEPENDENCE 285 0.0018
992 PRODUCT STORAGE ERROR 142 0.0016